Status:
COMPLETED
A Prospective Investigation Using the Expired Breath Ethanol Test
Lead Sponsor:
Daniel Stephan Engeler
Conditions:
Benign Prostatic Hyperplasia (BPH)
Eligibility:
MALE
40+ years
Brief Summary
Benign prostatic hyperplasia (BPH) is a prevalent entity, affecting over 50% of men older than 60 years.In cases with moderate to severe lower urinary tract symptoms (LUTS) monopolar transurethral res...
Detailed Description
Benign prostatic hyperplasia (BPH) is a prevalent entity, affecting over 50% of men older than 60 years.3 The clinical picture of the disease includes lower urinary tract symptoms such as interrupted ...
Eligibility Criteria
Inclusion
- Men older than 40
- Patient must be a candidate for TUV-P
- Refractory to medical therapy or patient is not willing to consider (further) medical treatment
- Written informed consent
Exclusion
- Mild symptoms (IPSS \<8)
- Urethral stenosis
- Bladder diverticulum (\>100ml)
- Former alcoholic or chronic liver disease
- Alcohol consumption 24h before operation
Key Trial Info
Start Date :
April 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2016
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT02304549
Start Date
April 1 2014
End Date
February 1 2016
Last Update
February 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cantonal Hospital St. Gallen
Sankt Gallen, Switzerland, 9007